Korea:000220

Yuyu Pharma to attend 'CPHI Worldwide 2023'

Retrieved on:

Wednesday, October 18, 2023

SEOUL, South Korea, Oct. 18, 2023 /PRNewswire/ -- Yuyu Pharma will be attending CPHI Worldwide in Barcelona, Spain from October 24th to October 26th.

Key Points:

SEOUL, South Korea, Oct. 18, 2023 /PRNewswire/ -- Yuyu Pharma will be attending CPHI Worldwide in Barcelona, Spain from October 24th to October 26th.
The Yuyu Business Development team will be able to meet great partners at booth #7G30 in the Korean Trade Association pavilion to introduce Yuyu's export products such as its modified new drug Maxmarvil EC Tablet, Yuhylyx soft capsules, Yuvaro, and Senuvela Tab, among others.
In particular, Yuyu will focus on promoting projects currently under development, such as a reduced sized Dutasteride and Dutasteride-Tamsulosin combination drug.
These projects are being developed with the goal of entering the U.S. and European Benign Prostate Hyperplasia
Danny Kang, Export Manager at Yuyu said "As always, we look forward to having active discussions with partners at our CPHI booth.

Yuyu Pharma to attend 'CPHI Worldwide 2023'

Retrieved on:

Wednesday, October 18, 2023

Dutasteride, Yuyu, Nightclub

SEOUL, South Korea, Oct. 18, 2023 /PRNewswire/ -- Yuyu Pharma will be attending CPHI Worldwide in Barcelona, Spain from October 24th to October 26th.

Key Points:

SEOUL, South Korea, Oct. 18, 2023 /PRNewswire/ -- Yuyu Pharma will be attending CPHI Worldwide in Barcelona, Spain from October 24th to October 26th.
The Yuyu Business Development team will be able to meet great partners at booth #7G30 in the Korean Trade Association pavilion to introduce Yuyu's export products such as its modified new drug Maxmarvil EC Tablet, Yuhylyx soft capsules, Yuvaro, and Senuvela Tab, among others.
In particular, Yuyu will focus on promoting projects currently under development, such as a reduced sized Dutasteride and Dutasteride-Tamsulosin combination drug.
These projects are being developed with the goal of entering the U.S. and European Benign Prostate Hyperplasia
Danny Kang, Export Manager at Yuyu said "As always, we look forward to having active discussions with partners at our CPHI booth.

Yuyu Healthcare Conducts Global Promotion at Vitafoods Asia 2023

Retrieved on:

Thursday, September 21, 2023

Growth, ODM, Patent, Animation, History, Pharmaceutical industry

SEOUL, South Korea, Sept. 21, 2023 /PRNewswire/ -- Yuyu Healthcare will participate in the Vitafoods Asia 2023 event in Bangkok, Thailand with the goal of entering the global market.

Key Points:

SEOUL, South Korea, Sept. 21, 2023 /PRNewswire/ -- Yuyu Healthcare will participate in the Vitafoods Asia 2023 event in Bangkok, Thailand with the goal of entering the global market.
Yuyu Healthcare will operate a booth at the event and focus on promoting its ODM health functional foods manufacturing technology.
Yuyu Healthcare will distribute animation videos that introduce its raw material development and patent registration portfolio as well as distribute formulation and packing samples.
Yuyu Healthcare's CEO said, "For the first time in its history, Yuyu Healthcare will be operating a booth at an international event such as Vitafoods Asia 2023.

Yuyu Healthcare Conducts Global Promotion at Vitafoods Asia 2023

Retrieved on:

Thursday, September 21, 2023

Growth, ODM, Patent, Animation, Multimedia, History, Pharmaceutical industry

SEOUL, South Korea, Sept. 21, 2023 /PRNewswire/ -- Yuyu Healthcare will participate in the Vitafoods Asia 2023 event in Bangkok, Thailand with the goal of entering the global market.

Key Points:

SEOUL, South Korea, Sept. 21, 2023 /PRNewswire/ -- Yuyu Healthcare will participate in the Vitafoods Asia 2023 event in Bangkok, Thailand with the goal of entering the global market.
Yuyu Healthcare will operate a booth at the event and focus on promoting its ODM health functional foods manufacturing technology.
Yuyu Healthcare will distribute animation videos that introduce its raw material development and patent registration portfolio as well as distribute formulation and packing samples.
Yuyu Healthcare's CEO said, "For the first time in its history, Yuyu Healthcare will be operating a booth at an international event such as Vitafoods Asia 2023.

Yuyu Pharma Plans to Enter the U.S. and European Markets for Hair Loss Treatment

Retrieved on:

Tuesday, November 29, 2022

There are plans to have a pre-IND meeting with the U.S. FDA and Scientific Advice meeting with Europe's EMA next year.

Key Points:

There are plans to have a pre-IND meeting with the U.S. FDA and Scientific Advice meeting with Europe's EMA next year.
Wonsang Robert Yu, CEO of Yuyu Pharma said "Dutasteride has been approved and is prescribed to patients with AGA in Korea and Japan.
But it is not approved as a hair loss treatment in the U.S. and Europe.
Yuyu Pharma (KRX: 000220) is a Korean pharmaceutical company founded in 1941 that manufactures and distributes pharmaceutical products, medical devices, and food supplements.

Yuyu Pharma Plans to Enter the U.S. and European Markets for Hair Loss Treatment

Retrieved on:

Tuesday, November 29, 2022

There are plans to have a pre-IND meeting with the U.S. FDA and Scientific Advice meeting with Europe's EMA next year.

Key Points:

There are plans to have a pre-IND meeting with the U.S. FDA and Scientific Advice meeting with Europe's EMA next year.
Wonsang Robert Yu, CEO of Yuyu Pharma said "Dutasteride has been approved and is prescribed to patients with AGA in Korea and Japan.
But it is not approved as a hair loss treatment in the U.S. and Europe.
Yuyu Pharma (KRX: 000220) is a Korean pharmaceutical company founded in 1941 that manufactures and distributes pharmaceutical products, medical devices, and food supplements.

Yuyu Pharma attendance at European Pharmaceutical Conference

Retrieved on:

Thursday, November 3, 2022

Urology, CEO, Therapy, Hope, KRX, Mission, Patient, Quality of life, DUT, Internet, Fine chemical, Pharmaceutical industry, Ophthalmology, Neurology

SEOUL, South Korea, Nov. 3, 2022 /PRNewswire/ --Robert Yu, CEO of Yuyu Pharma, has been attending biopharmaceutical conferences held in Germany, BIO-Europe and CPHI.

Key Points:

SEOUL, South Korea, Nov. 3, 2022 /PRNewswire/ --Robert Yu, CEO of Yuyu Pharma, has been attending biopharmaceutical conferences held in Germany, BIO-Europe and CPHI.
Yuyu Pharma is currently conducting Phase 2 clinical trials for YP-P10 in the United States at 7 sites with 240 patients.
Additionally, Robert Yu plans to meet with global pharmaceutical companies to discuss potential collaboration opportunities as well as meet with European officials in connection with regulatory affairs and drug registration.
Yuyu Pharma (KRX: 000220) is a Korean pharmaceutical company founded in 1941 that manufactures and distributes pharmaceutical products, medical devices, and food supplements.

Yuyu Pharma attendance at European Pharmaceutical Conference

Retrieved on:

Thursday, November 3, 2022

Mission, Urology, Patient, DUT, Hope, CEO, KRX, Internet, Therapy, Quality of life, Fine chemical, Pharmaceutical industry, Ophthalmology, Neurology

SEOUL, South Korea, Nov. 3, 2022 /PRNewswire/ --Robert Yu, CEO of Yuyu Pharma, has been attending biopharmaceutical conferences held in Germany, BIO-Europe and CPHI.

Key Points:

SEOUL, South Korea, Nov. 3, 2022 /PRNewswire/ --Robert Yu, CEO of Yuyu Pharma, has been attending biopharmaceutical conferences held in Germany, BIO-Europe and CPHI.
Yuyu Pharma is currently conducting Phase 2 clinical trials for YP-P10 in the United States at 7 sites with 240 patients.
Additionally, Robert Yu plans to meet with global pharmaceutical companies to discuss potential collaboration opportunities as well as meet with European officials in connection with regulatory affairs and drug registration.
Yuyu Pharma (KRX: 000220) is a Korean pharmaceutical company founded in 1941 that manufactures and distributes pharmaceutical products, medical devices, and food supplements.